U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854848) titled 'Cohort of Patients With Systemic Granulomatosis and Associated Biological Collection' on Feb. 25.
Brief Summary: The GRAMI-BIO study is a prospective single-centre cohort study to recruit 150 patients followed up in the the Bordeaux University Hospital. The total duration of the GRAMI-BIO study is ten years (five years of inclusion with five years of follow-up): Consecutive inclusion of patients meeting the definition of systemic granulomatosis. The main objective of this cohort is to describe to clinical progression of systemic granulomatosis and to collect blood fraction samples (serum bank, plasma bank, urine bank, DNA bank) from...